Catalyst Pharmaceuticals, Inc.
(NASDAQ : CPRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
4.67%20.192.0%$666.69m
SHPGShire PLC Sponsored ADR
1.68%175.050.4%$146.89m
GWPHGW Pharmaceuticals PLC Sponsored ADR
2.89%147.376.8%$143.94m
PRGOPerrigo Co. Plc
1.06%72.586.8%$100.72m
JAZZJazz Pharmaceuticals Plc
1.86%158.162.2%$68.60m
ENDPEndo International Plc
3.95%18.178.9%$64.46m
MNKMallinckrodt Plc
1.66%27.6321.1%$61.38m
ICPTIntercept Pharmaceuticals, Inc.
5.27%106.8818.7%$51.82m
SAGESAGE Therapeutics, Inc.
1.56%122.139.6%$49.10m
UTHRUnited Therapeutics Corporation
1.38%125.1214.4%$37.34m
CTLTCatalent Inc
2.60%42.652.4%$34.57m
ICLRICON Plc
3.02%148.524.1%$33.81m
AERIAerie Pharmaceuticals, Inc.
5.92%59.576.9%$28.73m
PCRXPacira Pharmaceuticals, Inc.
4.23%47.2410.6%$27.72m
MDCOMedicines Company
4.75%28.2121.8%$27.32m

Company Profile

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder. The company was founded by McEnany J. Patrick and Huckel E. Hubert in January 2002 and is headquartered in Coral Gables, FL.